PROGRAM*
L.
INTRODUCTION AND BACKGROUND
TANNENBAUM
Introduction
STEWART
A Brief Comparison of Lung Tumors in Man and
Laboratory Animals
KUSCHNER
Inhalation Induction of Experimental Lung Cancer-
A Critical Review
CONNING
The Irritant Effects of Tobacco Smoke
WYNDtR AND HOFFMANN
Experimental Skin and Lung Carcinogenesis Using
Tobacco Smoke
and its Particulate Matter: A Comparison of
Techniques
EFFECTS. ESPECIALLY INDtXTION OF TUMORS. PRODUCED
BY INHALATION
OF CIGARETTE SMOKE
OTTO
Experimental Investigations with Native Cigarette
Smoke and
the Gas-Phase of Cigarette Smoke on Mice
C. LEUCHTENBERGER AND R. LEUCHTENBERGER
Effects of Chronic Inhalation of Cigarette Smoke
on the
.Frequency of Pulmonary Tumors in Nice
The meetings begin at 9:00 A.M. Presentations
should be limited
to forty minutes. Inasmuch an this is a working
party, each
presentation will be followed by an unltmLtedt-
pattinent discus-:
sion. Therefore, no ex4ct time3 for the start of a
particular
presentation is given. There will be three breaks:
for' coffta
in the morning and'afternoon, and for lunch.
0 C
11 C
Location
medical School
Rue du Bugnon 9
Medical School
BATCo document for Province of BritiSh Columbia 4
November 1999


Loc3tion
HARRIS AND NEGRONI
Lung Tumor3 in C 57 b1 Mice Exposed to a Mixture
of
Air and Smoke
DONTENWILL
Earlier and Recent Investigations on the Effects
of
Cigarette Smoke
SHABAD
Effects of Cigarette Smoking by Rabbits and of
Intratracheal
Intubation of Tobacco Tar In Rats
AUERBACH
The Effect of Direct CigaretteSmoke Inhalation on
the
Respiratory Tree of Dog@
111. RATIONALE OF UESIGN OF INILALATIO14 EQUIPMENT
Cancer Institute
Rue du Bugnon 21
Session Leader: C. Leuchtenberger
DAVIS
A New Device for Exposing Animals to Cigarette
Smoke
IV. SUITABILITY OF VARIOUS SPECIES FOR BIOASSAY OF
CIGARETTE SMOKE Medical.Scho.l
V. SUMMATION AND CRITIQUE Medical School
Session Leader: R.J.C. Harris
TANNENBAUM
Dr, Henri Isliker, Director of the Swiss Institute
for
Experimental Cancer Research is our Host, and he
is
also in Charge of Local Arrangements. If you have
any
special problems. I feel sure that he or a
representa-
tive will try to help you. Dr. Isliker is
considering
a number of nnn-scientific events which we hope to
fit
into the program.
CZD
BATCo document for Province of BritiSh Columbia 4
November 1999


CARCINOGENESIS BY INHALATION,
WITH SPECIAL REFERENCE TO CIGARETTE SMOKE
Participants-and/or Contributors
Dr. 0. Auerbach Dr. R. Leuchtenberger
Veterans Administration Hospital Department of
Cytochemistry
East Orange, N, J. 07019 Swiss Institute for
Exper. Cancer Res.
21, rue du Bugnon
Dr. D. M. Conning 1005 Lausanne, Switzerland
Imperial Chemical Industries Limited
Industrial Hygiene Res. Laboratories Dr. G.
Neoroni
Alderley Park, Nr. Macclesfield Imperial Cancer
Research Fund
Cheshire, England Burtonhole Lane, The Ridgeway
London, N*W~7.9 England
Dr. B. Davis
Tobacco Res. Council Laboratories
Otley Road
Harlow Hill, Harrogate
Yorks, England
Dr. W. Dontenwill
-~nstituts der Wissenschaft. Forschungs.
im Verband der Cigarettenindustria
2000, Hamburg 54
Gazellenkamp 38, Germany
Dr. R.J.C. Harris
Dept. of Envir. Carcinogenesis
Imperial Cancer Research Fund
Burtonhole Lane, The Ridgeway
London, N.W.7., England
Dr. D. 11offmann
Sloan-Kettering Inst. for Cancer Res.
New York, New York 10021
Dr. M. Kuschner
Director of Laboratories
Bellevue Medical Center
New York University
550 First Ave.
New York, New York 10016
Dr. C. Leuchtenberger
Department of Cytochemistry
Swiss Institute for Exper. Cancer Res.
21, rue du Bugnon
1005 Lausanne, Switzerland
Dr. H. Otto
Pathologisch-Anatomischen Institut,
Erlangen-Nurnberg
8520 Erlangen
Germany
Dr. L. M. Shabad
Inst. of Exper. and Clin. Oncology
6-1/2 Stchepkin Street, Building C
Moscow T-110., U.S.S.R.
Dr. H. L. Stewart
Chief, Laboratory of Pathology
National Cancer Institute
Bethesda, Maryland 20014
Dr. A. Tannenbaum
Division of Cancer Research
Michael Reese Hospital & Medical Center
29 th Streetand Ellis Ave.
Chicago, Illinois 60616
Dr. E. L. Wynder
Sloan-Kettering Inst. for Cancer Res.
New York, New York 10021
. . . . . . . . . . . . . . . .
Dr. J. F. Delafresnays
Director, Geneva Office
International Union Against Cancer
P.O. Box 400
1211 Geneva 29 Switzerland
Dr. Henri Isliker, Director
Swiss Institute for Experimental
Cancer RC3esrch
21, rue du Bugnon
1005 Lausanne, Switzerland
cc
BATCo document for Province of BritiSh Columbia 4
November 1999